JAMP Pharma to invest Rs 250 crore in setting up huge facility

Canadian generic drug manufacturer JAMP Pharma will be setting up its biggest center of excellence for R&D and manufacturing of export quality drug formulations and will invest around Rs 250 crore.

According to an official release, the firm which will come up in the Genome Valley cluster here, is expected to generate 2,000 direct jobs over the next 24 months.

Telangana IT and Industries Minister KT Rama Rao assured the company of complete support from the Telangana government.

The city-based GeneSys Biologics, a specialty biotech company engaged in R&D of advanced biosimilars also announced the inauguration of its state-of-the-art biotechnology manufacturing facility in the Genome Valley.

Rama Rao Thursday unveiled several new projects in Genome Valley to the tune of Rs 800 crore, the release said.